Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Valo Health, Inc ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data.
INDIGO Biosciences Expands Autoimmune-Focused Preclinical Testing Portfolio
Share Article
Nuclear Factor of Activated T cells Assay Targets Preclinical Autoimmune and Oncology Research The addition of NFAT to our portfolio expands opportunities for autoimmune and oncology researchers to get the critical interaction and activation data they need, before entering costly clinical trials. STATE COLLEGE, Pa. (PRWEB) March 16, 2021 INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded their robust testing portfolio to include a new Nuclear Factor of Activate T cells (NFAT) assay used primarily for preclinical autoimmune research. This cell-based in vitro assay provides discovery researchers with the ability to quickly make critical decisions about potential drug candidates before moving into trials. NFAT is also implicated in the development of several diseases, including infl